International study on the strategic use of venture capital in managing innovation
Month: October 2011
Deal round-up: September 2011
This table summarises last month’s deal activity with a corporate venturing involvement.
The tide turns in perception of corporates
The concerns held by most entrepreneurs and other venture investors about corporate venturing units are outweighed by the positives they can bring.
Enlighted saves its energy for Intel
US-based lighting control company Enlighted closed a $14.2m round of financing on Tuesday with corporate venturing unit Intel Capital, and venture capital firms Kleiner Perkins Caufield & Byers and Draper Fisher Jurvetson participating. Enlighted’s last round raised $2.1m in January while the firm secured $1.1m in seed funding over the two years prior. Founded in… Continue reading Enlighted saves its energy for Intel
The Angel files: the corporate connection
How to set up a corporate angel fund and work with individuals
The Angel files: a matter of choice
How to choose a syndicate and help entrepreneurs.
Monitise and Morse: a venturing success
Case study on how venturing with Morse helped turn Monitise into a success.
Gaule’s Question Time: Takeda Ventures
As part of a series of interviews with leading innovation and venture developers, Andrew Gaule, founder of the Corporate Venturing Network, talks to Graeme Martin (pictured), president of Takeda Ventures.
Back to school for corporate venturing
There’s a right way to win, but a fast track to failure
Glori Energy eyes $115m IPO
The energy company backed by corporate venturing unit Energy Technology Ventures and venture firm Kleiner Perkins raised $26.5m in venture funding between November 2006 and May 2011.
Square circles $140m mark
The mobile payments company has closed two rounds of funding this year with participation from investors including credit card company Visa.
WhoSay speaks Greylock’s language
US-based celebrity media management platform WhoSay secured an undisclosed amount of funding from venture capital firm Greylock Partners on Monday. Online retailer Amazon and venture capital firm High Peak Ventures are among WhoSay’s existing investors. WhoSay closed its series A round, in June 2010, having raised $2.4m. WhoSay, which was co-founded by entertainment and sports agency… Continue reading WhoSay speaks Greylock’s language
Inventages backs Phagenesis
UK-based pharmaceutical company Phagenesis closed its €7m ($9.3m) of series B funding yesterday with Inventages, a life sciences firm backed by Switzerland-based food and nutrition corporation Nestlé, leading the round. Founded in 2007 after it span off from research performed at the University of Manchester, Phagenesis raised £2m ($3.1m) in a September 2010 series A… Continue reading Inventages backs Phagenesis
Creabilis’ prayers answered with Abbott’s help
Luxembourg-based biotechnology company Creabilis Therapeutics secured €15m ($20m) on Tuesday in a series B round led by Abbott Biotech Ventures, the corporate venturing unit for healthcare company Abbott Laboratories. Abbott was joined by investment firm Neomed, venture capital firm Sofinnova Partners and unnamed private investors. Sofinnova and Neomed previously backed Creabilis’ €20m series A round… Continue reading Creabilis’ prayers answered with Abbott’s help